PCVX Vaxcyte, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$56,48
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$39,8752-Wochen-Tief
$65,0052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$8.18B
P/E
-10.0
EPS
$-5.63
Ihre Abzeichen
52W-Spanne
$40–$65
Analystenbewertung
BUY
Kursziel
$109
P/E
-10.0
ROE
-26.6%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
PCVX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$56.48
Marktkapitalisierung (MRQ)
$8.18B
P/E
-10.0
EPS
$-5.63
ROE
-26.6%
52W-Spanne
$40–$65
PCVX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-5.632020-12-31 → 2025-12-31
Freier Cashflow$-669M2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | PCVX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -10.05-Jahres-Durchschnitt ≈-14.2 | ≈-14.2 | · | · | |
| K/B (MRQ) | 3.05-Jahres-Durchschnitt ≈3.7 | ≈3.7 | 9.0 | Unterbewertet | |
| Kurs / FCF (TTM) | -9.15-Jahres-Durchschnitt ≈-16.2 | ≈-16.2 | · | · | |
| Kurs / Cashflow (TTM) | -9.35-Jahres-Durchschnitt ≈-16.9 | ≈-16.9 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 2.85-Jahres-Durchschnitt ≈3.7 | ≈3.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | PCVX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -23.5%5-Jahres-Durchschnitt ≈-27.4% | ≈-27.4% | -18.4% | Schwach | |
| ROE | -26.6%5-Jahres-Durchschnitt ≈-27.8% | ≈-27.8% | -20.3% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | PCVX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 5.75-Jahres-Durchschnitt ≈12.1 | ≈12.1 | 6.7 | Geringe Liquidität | |
| Quick Ratio | 7.65-Jahres-Durchschnitt ≈11.8 | ≈11.8 | 3.6 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-9.8%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-1.97 | $-2.10 | 6.0% |
| 31. März 2026 | $-2.30 | $-1.79 | -28.7% | |
| 31. Dezember 2025 | $-1.80 | $-1.55 | -16.4% | |
| 30. September 2025 | $-1.56 | $-1.29 | -20.5% | |
| 30. Juni 2025 | $-1.22 | $-1.19 | -2.1% | |
| 31. März 2025 | $-1.04 | $-1.07 | 2.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $794M | $477M | $332M | $169M | $78M | $74M | $46M | |
| SG&A Expense | $129M | $93M | $61M | $40M | $25M | $16M | $9M | |
| Operating Expenses | $924M | $570M | $468M | $232M | $104M | $90M | $54M | |
| Operating Income | $-924M | $-570M | $-468M | $-232M | $-104M | $-90M | $-54M | |
| Interest Expense | · | · | $0 | $2.0K | $7.0K | $7.0K | $40.0K | |
| Interest Income | $120M | $110M | $63M | $8M | $344.0K | $244.0K | $632.0K | |
| Other Non-op | $37M | $-4M | $3M | $9M | $4M | $364.0K | $4M | |
| Income Tax | $0 | $0 | $0 | · | · | · | · | |
| Net Income | $-767M | $-464M | $-402M | $-223M | $-100M | $-89M | $-50M | |
| EPS (Basic) | $-5.63 | $-3.80 | $-4.14 | $-3.44 | $-1.93 | $-3.02 | · | |
| EPS (Diluted) | $-5.63 | $-3.80 | $-4.14 | $-3.44 | $-1.93 | $-3.02 | · | |
| Shares (Basic) | 136,089,506 | 121,997,348 | 97,157,690 | 64,877,988 | 51,922,108 | 29,545,810 | · | |
| Shares (Diluted) | 136,089,506 | 121,997,348 | 97,157,690 | 64,877,988 | 51,922,108 | 29,545,810 | · | |
| EBITDA | $-907M | $-563M | $-465M | $-230M | $-102M | $-88M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $174M | $388M | $397M | $835M | $69M | $386M | $59M | |
| Short-term Investments | $1.39B | $1.36B | $683M | $97M | $177M | · | · | |
| Prepaid Expense | $66M | $41M | $16M | $11M | $10M | $3M | $3M | |
| Other Current Assets | $2M | $2M | $2M | $2M | · | · | · | |
| Current Assets | $1.63B | $1.79B | $1.10B | $943M | $256M | $389M | $62M | |
| PP&E (Net) | $257M | $198M | $80M | $10M | $8M | $3M | $3M | |
| PP&E (Gross) | $290M | $214M | $89M | $16M | $12M | $7M | $6M | |
| Accum. Depreciation | $33M | $16M | $9M | $6M | $4M | $4M | $3M | |
| Other Non-current Assets | $119M | $64M | $38M | $5M | $4M | $550.0K | $584.0K | |
| Total Assets | $3.00B | $3.51B | $1.41B | $1.01B | $324M | $393M | $66M | |
| Accounts Payable | $71M | $48M | $15M | $10M | $7M | $30M | $3M | |
| Accrued Liabilities | $31M | $29M | $60M | $15M | $9M | $4M | $1M | |
| Current Liabilities | $206M | $140M | $145M | $41M | $29M | $47M | $11M | |
| Capital Leases | $111M | $65M | $22M | $12M | $12M | · | · | |
| Other Non-current Liabilities | $100.0K | $100.0K | $0 | $9.0K | $96.0K | $112.0K | $242.0K | |
| Total Liabilities | $317M | $205M | $167M | $53M | $40M | $47M | $12M | |
| Common Stock | $134.0K | $128.0K | $98.0K | $82.0K | $56.0K | $54.0K | $7.0K | |
| Retained Earnings | $-2.15B | $-1.39B | $-924M | $-522M | $-299M | $-199M | $-109M | |
| AOCI | $2M | $-4M | $179.0K | $-361.0K | $-241.0K | · | · | |
| Stockholders' Equity | $2.69B | $3.31B | $1.24B | $954M | $284M | $346M | $-106M | |
| Liabilities + Equity | $3.00B | $3.51B | $1.41B | $1.01B | $324M | $393M | $66M | |
| Shares Outstanding | 131,058,858 | 124,893,034 | 95,364,831 | 79,470,670 | 53,031,978 | 51,071,593 | 4,059,909 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $7M | $3M | $3M | $2M | $1M | $1M | |
| Stock-based Comp | $139M | $85M | $49M | $24M | $11M | $5M | $1M | |
| Other Non-cash | $-44M | $-81M | $54M | $27M | $-34M | $36M | · | |
| Operating Cash Flow | $-656M | $-453M | $-297M | $-171M | $-121M | $-47M | $-47M | |
| CapEx | $14M | $22M | $16M | $6M | $7M | $1M | $1M | |
| Investing Cash Flow | $437M | $-2.01B | $-773M | $75M | $-212M | $-1M | $-1M | |
| Stock Issued | · | $196M | $91M | $97M | $14M | $0 | · | |
| Net Stock Activity | · | $196M | $91M | $97M | $14M | · | · | |
| Financing Cash Flow | $2M | $2.45B | $640M | $862M | $18M | $375M | $42M | |
| Net Change in Cash | $-214M | $-9M | $-437M | $766M | $-316M | $327M | $-7M | |
| Free Cash Flow | $-669M | $-475M | $-313M | $-176M | $-128M | $-48M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -23.5% | -18.9% | -33.3% | -33.6% | -27.9% | -38.9% | · | |
| ROE | -26.6% | -13.8% | -30.4% | -34.0% | -33.9% | -25.1% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 12.8 | 7.5 | 23.3 | 8.9 | 8.3 | · | |
| Quick Ratio | 7.6 | 12.5 | 7.4 | 23.0 | 8.6 | 8.2 | · | |
| Interest Coverage | · | · | · | -116128.0 | -14810.0 | -12797.3 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $20.49 | $26.47 | $13.01 | $12.00 | $5.36 | $6.77 | · | |
| Cash Flow / Share | $-4.82 | $-3.71 | $-3.05 | $-2.63 | · | · | · | |
| Cash / Share | $1.33 | $3.11 | $4.17 | $10.50 | $1.30 | $7.56 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-5.63 | $-3.80 | $-4.14 | $-3.44 | $-1.93 | $-3.02 | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-767M | $-464M | $-402M | $-223M | $-100M | $-89M | · | |
| Market Cap | $6.05B | $10.22B | $5.99B | $3.81B | $1.26B | $1.36B | · | |
| P/E | -8.2 | -21.5 | -15.2 | -13.9 | -12.3 | -8.8 | · | |
| P/B | 2.3 | 3.1 | 4.8 | 4.0 | 4.4 | 3.9 | · | |
| P / Tangible Book | 2.3 | 3.1 | 4.8 | 4.0 | 4.4 | 3.9 | · | |
| P / Cash Flow | -9.2 | -22.6 | -20.2 | -22.3 | -10.4 | -29.1 | · | |
| P / FCF | -9.0 | -21.5 | -19.1 | -21.6 | -9.9 | -28.4 | · | |
| Earnings Yield | -12.2% | -4.6% | -6.6% | -7.2% | -8.1% | -11.4% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $268M | $313M | $242M | $210M | $194M | $148M | $134M | $117M | $132M | $95M | $104M | $97M | $73M | $58M | $52M | $48M | |
| SG&A Expense | $35M | $33M | $32M | $32M | $32M | $33M | $29M | $23M | $21M | $20M | $18M | $16M | $14M | $13M | $12M | $11M | |
| Operating Expenses | $303M | $346M | $274M | $242M | $226M | $181M | $162M | $140M | $153M | $114M | $197M | $113M | $87M | $71M | $87M | $59M | |
| Operating Income | $-303M | $-346M | $-274M | $-242M | $-226M | $-181M | $-162M | $-140M | $-153M | $-114M | $-197M | $-113M | $-87M | $-71M | $-87M | $-59M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | |
| Interest Income | $26M | $27M | $26M | $29M | $31M | $33M | $36M | $28M | $24M | $22M | $18M | $18M | $16M | $10M | $7M | $1M | |
| Other Non-op | $-7M | $-1M | $1M | $291.0K | $29M | $7M | $-11M | $9M | $465.0K | $-2M | $-47M | $20M | $19M | $11M | $9M | $660.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | |
| Net Income | $-284M | $-321M | $-247M | $-213M | $-167M | $-141M | $-137M | $-103M | $-129M | $-95M | $-181M | $-93M | $-68M | $-60M | $-78M | $-58M | |
| EPS (Basic) | $-1.97 | $-2.30 | $-1.81 | $-1.56 | $-1.22 | $-1.04 | $-1.02 | $-0.83 | $-1.10 | $-0.85 | $-1.83 | $-0.91 | $-0.70 | $-0.70 | $-1.03 | $-0.93 | |
| EPS (Diluted) | $-1.97 | $-2.30 | $-1.81 | $-1.56 | $-1.22 | $-1.04 | $-1.02 | $-0.83 | $-1.10 | $-0.85 | $-1.83 | $-0.91 | $-0.70 | $-0.70 | $-1.03 | $-0.93 | |
| Shares (Basic) | 144,494,106 | 139,506,680 | · | 136,196,512 | 136,033,746 | 135,690,949 | · | 123,693,461 | 117,256,561 | 111,690,951 | · | 101,668,655 | 98,057,870 | 86,206,817 | · | 61,989,347 | |
| Shares (Diluted) | 144,494,106 | 139,506,680 | · | 136,196,512 | 136,033,746 | 135,690,949 | · | 123,693,461 | 117,256,561 | 111,690,951 | · | 101,668,655 | 98,057,870 | 86,206,817 | · | 61,989,347 | |
| EBITDA | $-303M | $-343M | · | $-242M | $-226M | $-178M | · | $-140M | $-153M | $-113M | · | $-113M | $-87M | $-70M | · | $-59M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $183M | $261M | $174M | $281M | $307M | $347M | $388M | $1.05B | $519M | $612M | $397M | $545M | $531M | $380M | $835M | $278M | |
| Short-term Investments | $1.30B | $1.48B | $1.39B | $1.43B | $1.35B | $1.32B | $1.36B | $1.13B | $934M | $875M | · | $721M | $756M | $442M | · | $84M | |
| Prepaid Expense | $66M | $76M | $66M | $56M | $54M | $45M | $41M | $33M | $29M | $31M | · | $30M | $23M | $19M | · | $8M | |
| Other Current Assets | · | · | $2M | · | · | · | $2M | $3M | $1M | $2M | · | $1M | · | · | · | · | |
| Current Assets | $1.55B | $1.81B | $1.63B | $1.77B | $1.72B | $1.72B | $1.79B | $2.21B | $1.48B | $1.52B | · | $1.30B | $1.31B | $841M | · | $370M | |
| PP&E (Net) | $260M | $261M | $257M | $253M | $242M | $217M | $198M | $163M | $126M | $85M | · | $11M | $16M | $15M | · | $10M | |
| PP&E (Gross) | · | · | $290M | · | · | · | $214M | $177M | $138M | $95M | · | $20M | $24M | $22M | · | $15M | |
| Accum. Depreciation | · | · | $33M | · | · | · | $16M | $13M | $12M | $10M | · | $8M | $8M | $7M | · | $5M | |
| Other Non-current Assets | $193M | $156M | $119M | $107M | $95M | $76M | $64M | $60M | $53M | $46M | · | $3M | $3M | $4M | · | $5M | |
| Total Assets | $3.14B | $3.35B | $3.00B | $3.17B | $3.31B | $3.38B | $3.51B | $3.56B | $2.09B | $2.09B | · | $1.50B | $1.50B | $1.01B | · | $412M | |
| Accounts Payable | $101M | $63M | $71M | $49M | $31M | $21M | $48M | $18M | $10M | $22M | · | $16M | $16M | $12M | · | $5M | |
| Accrued Liabilities | $25M | $30M | $31M | $25M | $32M | $26M | $29M | $31M | $22M | $54M | · | $15M | $19M | $18M | · | $14M | |
| Current Liabilities | $271M | $242M | $206M | $200M | $154M | $97M | $140M | $124M | $83M | $87M | · | $86M | $60M | $53M | · | $39M | |
| Capital Leases | $109M | $110M | $111M | $79M | $80M | $81M | $65M | $18M | $18M | $20M | · | $8M | $9M | $11M | · | $13M | |
| Other Non-current Liabilities | · | · | $100.0K | · | · | · | $100.0K | · | · | · | · | $2.0K | $5.0K | $7.0K | · | $89.0K | |
| Total Liabilities | $380M | $352M | $317M | $279M | $234M | $178M | $205M | $142M | $101M | $107M | · | $93M | $69M | $63M | · | $53M | |
| Common Stock | $148.0K | $147.0K | $134.0K | $133.0K | $133.0K | $132.0K | $128.0K | $127.0K | $114.0K | $112.0K | · | $98.0K | $97.0K | $84.0K | · | $64.0K | |
| Retained Earnings | $-2.76B | $-2.48B | $-2.15B | $-1.91B | $-1.70B | $-1.53B | $-1.39B | $-1.25B | $-1.15B | $-1.02B | · | $-744M | $-651M | $-583M | · | $-444M | |
| AOCI | $-8M | $-7M | $2M | $856.0K | $-2M | $-322.0K | $-4M | $139.0K | $2M | $3M | · | $-2M | $-3M | $47.0K | · | $-657.0K | |
| Stockholders' Equity | $2.76B | $3.00B | $2.69B | $2.89B | $3.07B | $3.20B | $3.31B | $3.42B | $1.99B | $1.98B | $1.24B | $1.40B | $1.43B | $945M | $954M | $359M | |
| Liabilities + Equity | $3.14B | $3.35B | $3.00B | $3.17B | $3.31B | $3.38B | $3.51B | $3.56B | $2.09B | $2.09B | · | $1.50B | $1.50B | $1.01B | · | $412M | |
| Shares Outstanding | 144,785,934 | 144,314,981 | 131,058,858 | 130,029,111 | 129,816,472 | 128,939,412 | 124,893,034 | 124,429,862 | 110,575,993 | 108,755,731 | · | 95,099,101 | 93,812,533 | 80,640,851 | · | 60,572,692 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $7M | $3M | $3M | $3M | $3M | $2M | $1M | $999.0K | $888.0K | $806.0K | $750.0K | $712.0K | $959.0K | $684.0K | |
| Stock-based Comp | $41M | $38M | $36M | $35M | $37M | $31M | $24M | $21M | $22M | $18M | $13M | $13M | $13M | $10M | $7M | $7M | |
| Other Non-cash | · | $-914.0K | · | · | · | $-59M | · | · | · | $-83M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-232M | $-281M | $-225M | $-143M | $-121M | $-166M | $-111M | $-61M | $-121M | $-159M | $-129M | $-58M | $-63M | $-48M | $-65M | $-39M | |
| CapEx | $4M | $2M | $3M | $4M | $2M | $5M | $4M | $5M | $8M | $6M | $5M | $7M | $-2M | $6M | $1M | $843.0K | |
| Investing Cash Flow | $148M | $-233M | $115M | $121M | $78M | $123M | $-557M | $-917M | $-80M | $-451M | $-14M | $22M | $-334M | $-448M | $-36M | $35M | |
| Stock Issued | · | · | · | · | · | · | · | $89M | $107M | $0 | · | $49M | $0 | $42M | $2M | $43M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $42M | · | · | |
| Financing Cash Flow | $6M | $602M | $2M | $-4M | $3M | $759.0K | $5M | $1.52B | $110M | $818M | $3M | $49M | $547M | $42M | $657M | $44M | |
| Net Change in Cash | $-78M | $87M | $-107M | $-26M | $-40M | $-41M | $-662M | $532M | $-93M | $214M | $-148M | $14M | $151M | $-454M | $556M | $40M | |
| Free Cash Flow | · | $-283M | · | · | · | $-172M | · | · | · | $-165M | · | · | · | $-53M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.8% | -9.5% | · | -6.3% | -6.2% | -5.1% | · | -4.1% | -7.2% | -6.1% | · | -9.7% | -7.1% | -8.6% | · | -15.1% | |
| ROE | -9.8% | -10.3% | · | -6.8% | -6.6% | -5.4% | · | -4.3% | -7.5% | -6.5% | · | -10.5% | -7.6% | -9.3% | · | -17.4% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.5 | · | 8.8 | 11.1 | 17.7 | · | 17.9 | 17.9 | 17.4 | · | 15.1 | 21.8 | 15.9 | · | 9.4 | |
| Quick Ratio | 5.5 | 7.2 | · | 8.6 | 10.8 | 17.2 | · | 17.6 | 17.5 | 17.1 | · | 14.8 | 21.4 | 15.6 | · | 9.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $19.05 | $20.76 | · | $22.25 | $23.66 | $24.82 | · | $27.47 | $17.96 | $18.24 | · | $14.75 | $15.28 | $11.72 | · | $5.93 | |
| Cash Flow / Share | · | $-2.01 | · | · | · | $-1.23 | · | · | · | $-1.42 | · | · | · | $-0.55 | · | · | |
| Cash / Share | $1.27 | $1.81 | · | $2.16 | $2.36 | $2.69 | · | $8.44 | $4.69 | $5.62 | · | $5.73 | $5.66 | $4.72 | · | $4.60 | |
| Dividend / Share | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| EPS (TTM) | $-7.64 | $-6.89 | · | $-4.84 | $-4.11 | $-3.99 | · | $-4.61 | $-4.69 | $-4.29 | · | $-3.34 | $-3.36 | $-3.46 | · | $-2.95 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-1.06B | $-947M | · | $-657M | $-547M | $-510M | · | $-508M | $-497M | $-437M | · | $-300M | $-265M | $-245M | · | $-174M | |
| Market Cap | $8.42B | $8.39B | · | $4.68B | $4.22B | $4.87B | · | $14.22B | $8.35B | $7.43B | · | $4.85B | $4.68B | $3.02B | · | $1.45B | |
| P/E | -7.6 | -8.4 | · | -7.4 | -7.9 | -9.5 | · | -24.8 | -16.1 | -15.9 | · | -15.3 | -14.9 | -10.8 | · | -8.1 | |
| P/B | 3.1 | 2.8 | · | 1.6 | 1.4 | 1.5 | · | 4.2 | 4.2 | 3.7 | · | 3.5 | 3.3 | 3.2 | · | 4.0 | |
| P / Tangible Book | 3.1 | 2.8 | · | 1.6 | 1.4 | 1.5 | · | 4.2 | 4.2 | 3.7 | · | 3.5 | 3.3 | 3.2 | · | 4.0 | |
| P / Cash Flow | · | -29.9 | · | · | · | -29.3 | · | · | · | -46.7 | · | · | · | -63.4 | · | · | |
| Earnings Yield | -13.1% | -11.9% | · | -13.4% | -12.6% | -10.6% | · | -4.0% | -6.2% | -6.3% | · | -6.6% | -6.7% | -9.2% | · | -12.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-767M | $-464M | $-402M | $-223M | $-100M |
| Verwässerte EPS | $-5.63 | $-3.80 | $-4.14 | $-3.44 | $-1.93 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 7.9 | 12.8 | 7.5 | 23.3 | 8.9 |
| Quick Ratio | 7.6 | 12.5 | 7.4 | 23.0 | 8.6 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-669M | $-475M | $-313M | $-176M | $-128M |
Institutionelle Eigentümer (13F) 365 Einreicher · $9.6B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
365
Gehaltener Wert
$9.6B
Neue Positionen
48
Geschlossene Positionen
46
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 48 (-28 vs. Vorquartal) | 46 (+23 vs. Vorquartal) | 141 (+6 vs. Vorquartal) | 100 (+22 vs. Vorquartal) | -9.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $1.212.179.482 | 20.852.907 | 12,58% | Aktien |
| JANUS HENDERSON GROUP PLC | $960.231.221 | 16.575.875 | 9,97% | Aktien |
| BlackRock, Inc. | $701.520.339 | 12.068.129 | 7,28% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $667.018.440 | 11.474.599 | 6,92% | Aktien |
| VANGUARD GROUP INC | $562.630.515 | 12.193.986 | 5,84% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $407.000.973 | 7.001.565 | 4,23% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $383.283.120 | 6.593.551 | 3,98% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $369.048.710 | 6.348.679 | 3,83% | Aktien |
| STATE STREET CORP | $311.090.172 | 5.351.698 | 3,23% | Aktien |
| Deep Track Capital, LP | $249.959.000 | 4.300.000 | 2,59% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $201.130.269 | 3.459.363 | 2,09% | Aktien |
| Kynam Capital Management, LP | $169.875.334 | 2.922.335 | 1,76% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $143.722.240 | 2.472.428 | 1,49% | Aktien |
| Caligan Partners LP | $127.225.411 | 2.188.636 | 1,32% | Aktien |
| Paradigm Biocapital Advisors LP | $123.692.037 | 2.127.852 | 1,28% | Aktien |
| Bellevue Group AG | $114.628.582 | 1.971.935 | 1,19% | Aktien |
| D. E. Shaw & Co., Inc. | $110.555.819 | 1.901.872 | 1,15% | Aktien |
| MAVERICK CAPITAL LTD | $93.777.757 | 1.613.242 | 0,97% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $85.149.522 | 1.464.812 | 0,88% | Aktien |
| Pivotal bioVenture Partners Investment Advisor LLC | $82.862.571 | 1.425.470 | 0,86% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $80.229.411 | 1.380.219 | 0,83% | Aktien |
| GOLDMAN SACHS GROUP INC | $78.519.679 | 1.350.760 | 0,82% | Aktien |
| NORTHERN TRUST CORP | $74.416.399 | 1.280.172 | 0,77% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $72.929.898 | 1.254.600 | 0,76% | Verkaufsoption |
| NORGES BANK | $72.418.645 | 1.245.805 | 0,75% | Aktien |
| JPMORGAN CHASE & CO | $71.190.303 | 1.227.346 | 0,74% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $69.446.041 | 1.194.754 | 0,72% | Aktien |
| Polar Capital Holdings Plc | $68.938.867 | 1.185.943 | 0,72% | Aktien |
| BANK OF AMERICA CORP /DE/ | $62.710.550 | 1.078.798 | 0,65% | Aktien |
| Caption Management, LLC | $60.873.736 | 1.047.200 | 0,63% | Verkaufsoption |
| VANGUARD FIDUCIARY TRUST CO | $54.098.219 | 930.642 | 0,56% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $51.154.400 | 880.000 | 0,53% | Aktien |
| Saturn V Capital Management LP | $49.579.891 | 852.914 | 0,51% | Aktien |
| Capital Research Global Investors | $48.640.917 | 836.761 | 0,50% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $47.242.251 | 812.700 | 0,49% | Kaufoption |
| NOVO HOLDINGS A/S | $46.504.000 | 800.000 | 0,48% | Aktien |
| MORGAN STANLEY | $46.371.409 | 797.718 | 0,48% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $45.468.483 | 782.184 | 0,47% | Aktien |
| UBS Group AG | $45.138.585 | 776.511 | 0,47% | Aktien |
| Clearbridge Investments, LLC | $43.713.700 | 751.999 | 0,45% | Aktien |
| Pictet Asset Management Holding SA | $40.384.015 | 694.719 | 0,42% | Aktien |
| Caption Management, LLC | $37.767.061 | 649.700 | 0,39% | Kaufoption |
| Eversept Partners, LP | $36.619.110 | 629.952 | 0,38% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $35.726.698 | 614.600 | 0,37% | Verkaufsoption |
| JANE STREET GROUP, LLC | $35.162.837 | 604.900 | 0,37% | Verkaufsoption |
| FEDERATED HERMES, INC. | $34.945.488 | 601.161 | 0,36% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $31.050.895 | 534.163 | 0,32% | Aktien |
| ALGERT GLOBAL LLC | $29.956.889 | 515.343 | 0,31% | Aktien |
| Bank of New York Mellon Corp | $29.189.124 | 502.135 | 0,30% | Aktien |
| BROWN ADVISORY INC | $28.310.299 | 487.017 | 0,29% | Aktien |
Unternehmensinsider 27 Insider · 10 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Grant Pickering | CHIEF EXECUTIVE OFFICER | 8. September 2026 F | 429.902 | 0 | 19 | $-3.634.889 |
| Andrew Guggenhime | PRESIDENT AND CFO | 8. September 2026 F | 95.316 | 0 | 5 | $-1.641.731 |
| Jim Wassil | EVP, Chief Scientific Ofc, COO | 1. Oktober 2026 M | 145.435 | 0 | 20 | $-1.557.861 |
| Elvia Cowan | SVP, Finance & CAO | 8. September 2026 F | 27.860 | 0 | 6 | $-988.635 |
| Harpreet S. Dhaliwal | Chief Technical Ops Officer | 8. September 2026 F | 68.085 | 0 | 2 | $-1.389.901 |
| Luis Jodar | Chief Medical Officer | 4. September 2026 A | 52.632 | 0 | 0 | $0 |
| Mikhail Eydelman | SVP, GEN COUNSEL & CORP SEC | 5. März 2025 M | 41.620 | 0 | 0 | $0 |
| Jeff Fairman | VP, Research | 30. Dezember 2022 A | 286.227 | 0 | 0 | $0 |
| Paul Sauer | SVP Process Dev, Manufacturing | 30. Dezember 2022 A | 13.822 | 0 | 0 | $0 |
| Jane Wright Mitchell | General Counsel | 16. August 2021 M | 3.125 | 0 | 0 | $0 |
| John Markels | Direktor | 16. Juli 2026 A | · | 0 | 0 | $0 |
| Moncef Slaoui | Direktor | 22. Juni 2026 A | · | 0 | 0 | $0 |
| Jacks Lee | Direktor | 15. Juni 2026 A | 6.856 | 0 | 0 | $0 |
| Teri Loxam | Direktor | 15. Juni 2026 A | 12.481 | 0 | 0 | $0 |
| John Furey | Direktor | 15. Juni 2026 A | 5.306 | 0 | 0 | $0 |
| Carlos V Paya | Direktor | 15. Juni 2026 A | 6.856 | 0 | 0 | $0 |
| Halley E Gilbert | Direktor | 15. Juni 2026 A | 12.481 | 0 | 0 | $0 |
| Heath Lukatch | Direktor | 15. Juni 2026 A | 19.481 | 0 | 0 | $0 |
| Olivier Brandicourt | Direktor | 15. Juni 2026 A | 4.699 | 0 | 0 | $0 |
| Anne S Drapeau | Direktor | 15. Juni 2026 A | 12.481 | 0 | 0 | $0 |
| Peter Hirth | Direktor | 6. Juni 2024 A | 7.175 | 0 | 0 | $0 |
| Michael E. Kamarck | Direktor | 13. Juni 2023 A | 5.625 | 0 | 0 | $0 |
| Robert Lorne Hopfner | Direktor | 2. Juni 2021 A | 1.405.418 | 0 | 0 | $0 |
| Patrick J. Heron | Direktor | 2. Juni 2021 A | 2.309.554 | 0 | 0 | $0 |
| Kurt Von Emster | Direktor | 2. Juni 2021 A | 4.168.718 | 0 | 0 | $0 |
| William J Newell | Direktor | 9. Dezember 2020 A | 66.684 | 0 | 0 | $0 |
| Abingworth LLP | 10%-Eigentümer | 11. Juni 2020 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 49 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 2,06% | 15.695 NS | 31. Juli 2026 | N-PORT |
| JXX · Janus Detroit Street Trust | 1,76% | 8.672 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,81% | 74.294 NS | 31. Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,76% | 6.549 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,62% | 1.079.439 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,56% | 10.515 SH | 2. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,34% | 836.418 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,30% | 95.213 SH | 19. August 2026 | Täglich |
| IQSM · New York Life Investments ETF Trust | 0,29% | 17.582 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,25% | 3.367.565 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,25% | 11.628 SH | 2. Oktober 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,23% | 1.911.818 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,23% | 758.123 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,23% | 63.087 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,23% | 1.015 NS | 31. Juli 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,21% | 58.584 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,21% | 71.663 SH | 19. August 2026 | Täglich |
| BKMC · BNY Mellon ETF Trust | 0,19% | 23.130 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,18% | 84.781 SH | 2. Oktober 2026 | Täglich |
| FFLG · FIDELITY COVINGTON TRUST | 0,17% | 18.030 NS | 31. Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,16% | 37.325 SH | 19. August 2026 | Täglich |
| ESSC · Strategy Shares | 0,16% | 1.044 NS | 31. Juli 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 56.781 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,15% | 24.427 SH | 11. September 2026 | Täglich |
| ESML · iShares Trust | 0,14% | 64.196 SH | 10. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,11% | 320.390 NS | 31. Juli 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,10% | 3.311.956 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,10% | 367.549 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,10% | 58.132 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,09% | 1.507.400 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,07% | 7.424 SH | 10. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,03% | 2.901 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,03% | 245.965 NS | 31. Juli 2026 | N-PORT |
| FBCG · FIDELITY COVINGTON TRUST | 0,03% | 32.976 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 12.523 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,02% | 7.426 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 32.072 NS | 31. Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,01% | 5.488 SH | 10. September 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 171.199 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 34.426 SH | 10. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,01% | 39.051 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 4.588.975 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 105.104 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 10.861 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,01% | 29.043 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 402.389 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 5.835 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 11.665 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 8.696 SH | 19. August 2026 | Täglich |
PCVX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 17 Analysten
KAUF
Median-Ziel
$110.00
+94,8%
7 41,2%
Starker Kauf
8 47,1%
Kauf
2 11,8%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
9 Analysten · 2026-10-01Mittelwert-Ziel $108.67 +92,4%
← Unter allen Zielen
Aktueller Preis $56.48
Tief$67.00
Mittelwert$108.67
Hoch$163.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PCVX | $6.05B | -8.2 | · | · | -26.6% | · |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | · |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | · |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | · |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | · |
| PRAX | $7.43B | -21.9 | 249.5% | · | -47.3% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | · |
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026